دورية أكاديمية
Screening for atrial fibrillation: the role of CHA 2 DS 2 -VASc and atrial fibrillation burden.
| العنوان: | Screening for atrial fibrillation: the role of CHA |
|---|---|
| المؤلفون: | Xing LY; Department of Cardiology, Heart Center, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark., Vad OB; Department of Cardiology, Heart Center, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.; Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Engler D; Department of Cardiology, University Heart and Vascular Center Hamburg Eppendorf, Hamburg, Germany.; German Centre for Cardiovascular Research (DZHK), Partner Site Hamburg/Kiel/Lübeck, Hamburg, Germany., Svendsen JH; Department of Cardiology, Heart Center, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Diederichsen SZ; Department of Cardiology, Heart Center, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark. |
| المصدر: | European heart journal supplements : journal of the European Society of Cardiology [Eur Heart J Suppl] 2024 Jul 31; Vol. 26 (Suppl 4), pp. iv41-iv49. Date of Electronic Publication: 2024 Jul 31 (Print Publication: 2024). |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Oxford University Press Country of Publication: England NLM ID: 100886647 Publication Model: eCollection Cited Medium: Print ISSN: 1520-765X (Print) Linking ISSN: 1520765X NLM ISO Abbreviation: Eur Heart J Suppl Subsets: PubMed not MEDLINE |
| أسماء مطبوعة: | Publication: 2005- : Oxford : Oxford University Press Original Publication: London, U.K. : Saunders, c1999- |
| مستخلص: | Individuals with subclinical atrial fibrillation (AF) face an increased risk of thromboembolic events, which may potentially be mitigated through AF screening and subsequent anticoagulation. However, data from randomized clinical trials (RCTs) indicate a lower stroke risk in subclinical AF compared with the clinical phenotype. This-along with the inherent bleeding risk related to anticoagulation-seems to render the net clinical benefit of AF screening less evident. Further, current guidelines recommend consideration of CHA Competing Interests: Conflict of interest: L.Y.X., O.B.V., and D.E. have no conflicts of interest to report. J.H.S. reports to be a member of Vital Beats and Medtronic advisory boards and to have received speaker honoraria and research grants from Medtronic outside this work. S.Z.D. reports to be a part-time employee of Vital Beats and advisor at Bristol Myers Squibb/Pfizer, not related to this work. (© The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology.) |
| References: | Circulation. 2024 Mar 26;149(13):981-988. (PMID: 37952187) Lancet. 2021 Oct 23;398(10310):1498-1506. (PMID: 34469764) Int J Cardiol. 2023 Jan 1;370:197-203. (PMID: 36328113) Eur Heart J Open. 2022 Jul 14;2(4):oeac044. (PMID: 35919582) Am J Cardiol. 2023 Oct 15;205:457-464. (PMID: 37666019) Circulation. 2017 Oct 3;136(14):1276-1283. (PMID: 28778946) J Am Coll Cardiol. 2019 Dec 3;74(22):2771-2781. (PMID: 31779791) Eur Heart J. 2018 Apr 21;39(16):1407-1415. (PMID: 29340587) Int J Cardiovasc Imaging. 2024 Mar;40(3):591-599. (PMID: 38245893) Circ Cardiovasc Imaging. 2024 Mar;17(3):e016197. (PMID: 38440875) J Am Heart Assoc. 2022 Sep 20;11(18):e027031. (PMID: 36073645) Circulation. 2022 Mar 29;145(13):946-954. (PMID: 35232217) Circulation. 2015 Jun 23;131(25):2176-84. (PMID: 25910800) Europace. 2020 May 1;22(5):724-731. (PMID: 32125356) Eur Heart J. 2015 Feb 1;36(5):281-7a. (PMID: 25187524) Ann Intern Med. 2007 Jun 19;146(12):857-67. (PMID: 17577005) Europace. 2021 Jan 27;23(1):29-38. (PMID: 33020819) Circulation. 1998 Sep 8;98(10):946-52. (PMID: 9737513) J Am Heart Assoc. 2024 Feb 20;13(4):e032744. (PMID: 38353260) JAMA Cardiol. 2021 May 1;6(5):558-567. (PMID: 33625468) Circulation. 2023 Jun 13;147(24):1788-1797. (PMID: 37061802) Circulation. 2024 Jan 2;149(1):e1-e156. (PMID: 38033089) Neurology. 2007 Aug 7;69(6):546-54. (PMID: 17679673) N Engl J Med. 2023 Sep 28;389(13):1167-1179. (PMID: 37622677) Eur Heart J. 2017 May 01;38(17):1339-1344. (PMID: 28329139) JAMA Neurol. 2022 Oct 1;79(10):997-1004. (PMID: 36036546) Eur Heart J. 2014 Feb;35(8):508-16. (PMID: 24334432) JAMA. 2018 Jul 10;320(2):146-155. (PMID: 29998336) Lancet Neurol. 2021 Jun;20(6):426-436. (PMID: 34022169) JACC Cardiovasc Imaging. 2020 Aug;13(8):1690-1700. (PMID: 32563642) Europace. 2017 Feb 01;19(2):297-302. (PMID: 28011798) N Engl J Med. 2014 Jun 26;370(26):2478-86. (PMID: 24963567) BMJ. 2011 Jan 31;342:d124. (PMID: 21282258) TH Open. 2024 Jan 08;8(1):e19-e30. (PMID: 38197016) N Engl J Med. 2024 Jan 11;390(2):107-117. (PMID: 37952132) Eur Heart J. 2021 Feb 1;42(5):373-498. (PMID: 32860505) Hypertension. 2022 Sep;79(9):2081-2090. (PMID: 35862138) JAMA. 2021 Jun 1;325(21):2160-2168. (PMID: 34061146) Int J Stroke. 2015 Aug;10(6):801-7. (PMID: 26148134) Neurology. 2021 Mar 23;96(12):557-559. (PMID: 33568549) Circulation. 2019 May 28;139(22):2502-2512. (PMID: 30880434) Circulation. 2019 Nov 12;140(20):1639-1646. (PMID: 31564126) Circulation. 2014 Feb 25;129(8):837-47. (PMID: 24345399) Lancet. 2021 Oct 23;398(10310):1507-1516. (PMID: 34469766) Eur Heart J. 2024 Mar 7;45(10):837-849. (PMID: 37956458) N Engl J Med. 2012 Jan 12;366(2):120-9. (PMID: 22236222) Circulation. 2024 Feb 20;149(8):e347-e913. (PMID: 38264914) Circulation. 2017 Nov 7;136(19):1784-1794. (PMID: 28851729) Eur Heart J Cardiovasc Imaging. 2023 Apr 24;24(5):625-634. (PMID: 36691845) Eur Heart J. 2016 May 21;37(20):1582-90. (PMID: 26920728) Circulation. 2020 May 12;141(19):1510-1522. (PMID: 32114796) Stroke. 1991 Aug;22(8):983-8. (PMID: 1866765) Chest. 2010 Feb;137(2):263-72. (PMID: 19762550) N Engl J Med. 2022 Oct 13;387(15):1385-1394. (PMID: 36027560) Europace. 2023 May 19;25(5):. (PMID: 37068888) Lancet Neurol. 2017 Apr;16(4):282-290. (PMID: 28187920) PLoS One. 2021 Oct 5;16(10):e0258276. (PMID: 34610049) |
| فهرسة مساهمة: | Keywords: Anticoagulation; Atrial fibrillation; Screening; Stroke |
| تواريخ الأحداث: | Date Created: 20240805 Latest Revision: 20240806 |
| رمز التحديث: | 20240806 |
| مُعرف محوري في PubMed: | PMC11292411 |
| DOI: | 10.1093/eurheartjsupp/suae078 |
| PMID: | 39099574 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1520-765X |
|---|---|
| DOI: | 10.1093/eurheartjsupp/suae078 |